Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from China NT Pharma Group Co., Ltd. ( (HK:1011) ) is now available.
China NT Pharma Group Co., Ltd., a Cayman Islands–incorporated pharmaceutical company listed in Hong Kong under stock code 1011, has outlined the composition of its board of directors, including executive, non-executive and independent non-executive members. The board is led by chairman Mr. Ng Tit and includes Ms. Ng Anna Ching Mei, Dr. Qian Wei, Ms. Chin Yu, Mr. Lou Yongbin, Mr. Yu Tze Shan Hailson, Dr. Zhao Yubiao and Mr. Kwok Che Chung.
The company also detailed membership of its three key board committees: the audit committee, the remuneration committee and the nomination committee. Committee leadership is concentrated among the independent non-executive directors, indicating an emphasis on governance and oversight, with specific roles allocated to ensure checks and balances across financial reporting, pay structures and board appointments as part of its corporate governance framework.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. is a pharmaceutical company listed in Hong Kong under stock code 1011 and incorporated in the Cayman Islands with limited liability. The group operates in the healthcare and pharmaceuticals sector, focusing on drug-related products and services within the Greater China market and beyond, serving hospitals, healthcare providers and patients.
Average Trading Volume: 322,111
Technical Sentiment Signal: Sell
Current Market Cap: HK$597.9M
For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.